🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr Harry McNaughton, MRINZ Stroke/Rehabilitation Research programme director, had a brilliant 'Taking Charge' intervention conversation with Kathryn Ryan on RNZ - Nine To Noon today. 🎙️📻👂 👉bit.ly/3bCMWfl #stroke #strokes #strokerecovery #strokesurvivor #strokeawareness

Every New Zealander who gets vaccinated helps protect our health system so that we can continue to help people (with and without COVID) when they get sick.

We recently welcomed our brilliant new colleagues Zamir and Sajida to the MRINZ whānau. We're all so thankful for the dedicated mahi of the Rīpeka Whero Aotearoa | New Zealand Red Cross Pathways to Employment programme, which helped connect Zamir and Sajida with the MRINZ.

“Professor Young and his MRINZ ICU Research team have dedicated years to examining the safety and efficacy of intravenous fluids, and these latest findings are likely to be regarded as the definitive word on this topic.” Professor Richard Beasley, MRINZ director. #PLUStrial NEJM

This #IWD2022 we acknowledge and celebrate the achievements of all the remarkable women of the MRINZ, recognising their significant contribution to clinical research and innovation in Aotearoa New Zealand. ♀️🧬#breakthebias2022 #womeninscience #researchlife #GenderEquity

This #WorldAsthmaDay we're thankful to all those involved in our current CARE 'Children's Anti-inflammatory REliever' study. We're especially grateful to all the brilliant tamariki across Aotearoa helping us find which inhaler is better at preventing asthma attacks in kids.😮‍💨

We’re hugely grateful for the core Independent Research Organisation (IRO) funding just awarded by the HRC New Zealand. Ka tuku oha hoki ki a Te Atawhai o Te Ao, #WhakauaeResearch, and the Malaghan Institute who also received HRC IRO support in this funding round.

Happy 2nd Anniversary #MegaRox. 🎉 It's two years today since the MRINZ Mega-ROX team started investigating the optimal oxygen regimen in critically ill patients in the largest intensive care clinical trial ever undertaken.

Happy International #ClinicalTrialsDay! Here’s our recently published ✨MRINZ 2021 Annual Research Report✨ for some #ICTD2022 reading. 👉📖 bit.ly/39DiSCh

This Te Wiki Tūao ā-Motu National Volunteer Week we celebrate our generous MRINZ study volunteer whānau. Without our incredible clinical trial participants, our research mahi is simply not possible. #NVW2022 #AotearoaOfKindness

Meet Alec, Ronan, and Alexsys, three of the generous kids who have stepped up to participate in our nationwide landmark CARE Study — and stars of a Newshub story this weekend. ⭐📺⭐ newshub.co.nz/home/new-zeala…

Ngā mihi nui to Dr Matire Harwood, MRINZ deputy director, who has this week received a service medal from the Royal New Zealand College of GPs, for her services toward Māori health during the Covid-19 pandemic.🏅✨ rnz.co.nz/news/te-manu-k…

Today the Mega-ROX activated their 50th site — National Hospital and Medical Centre in Pakistan. 🙌This is a brilliant milestone for the #MegaROX team as they undertake the world's largest critical care study of oxygen in ventilated ICU patients.

Results from a Landmark ICU study, published today in the NEJM, had an early morning share by Paul Young on Newshub. 📺 TEAM shows early active exercise in adults receiving life support can be harmful. HRC New Zealand, Prof Carol Hodgson, ANZICS, ANZICS Clinical Trials Group

What is the effect of treatment for critically ill patients with COVID-19 on longer-term mortality, disability, and health-related quality of life? Our JAMA Network publication informs the latest six-month outcome findings from the remap-cap study.

Dr Harry McNaughton's recent Clinical Rehab editorial argues the need for rehabilitation medicine to move away from its standard physical therapy-intensive approach by incorporating a patient-centred model informed by individual circumstances and motivations.

The 8-year PATCH Team study, published today in NEJM, shines a new light on tranexamic acid’s role in pre-hospital treatment of major trauma. ➡️ bit.ly/3CB8arb. Paul Young describes this as "a milestone in trauma care." @WgtnFree Hato Hone St John ANZICS Clinical Trials Group HRC New Zealand

Here’s Paul Young, MRINZ deputy director & study author’s detailed summary of the PATCH Team. Published today and undertaken in NZ in partnership with @WgtnFree + Hato Hone St John, this landmark pre-hospital study in patients with severe injuries raises important and complex questions.